Acute ischemic stroke. Stroke, not specified as haemorrhage or infarction
Conditions
Interventions
Intervention 1: Ritalin, 10 mg capsules orally, once daily for 14 days. Intervention 2: Placebo, 10 mg capsules orally, once daily for 14 days.
Treatment - Drugs
Placebo
Ritalin, 10 mg capsules orally, once daily for 14 days
Placebo, 10 mg capsules orally, once daily for 14 days
Sponsors
Vice chancellor for research, Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
45 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients with acute ischemic stroke; signed informed consent form and a questionnaire. Exclusion criteria: patients younger than 45 years (due to the low prevalence CVA) and for different reasons of CVA; patients with GCS <12; people who are allergic to Ritalin; with glaucoma; people with brainstem stroke and stroke cerebeller; who have dementia; with Psychosis; Unstable Arrhythmia; CHF; Unstable Angina; those already have used drugs MAOI and drugs agonists or antagonists, a-adrenergic , who already had CVA and the CVA this problem because they have a disability previous neurological deficit, those based on FMS, score 80-100 have received.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Motor function. Timepoint: Before the intervention, 2 weeks after the intervention, 10 weeks after intervention. Method of measurement: Based on the criteria for FMS. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactArash Bostani
Kermanshah University of Medical Sciences
Outcome results
None listed